mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.

mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
复制标题

DOI:
10.1038/onc.2017.360
复制
发表时间:
2018-02-08
期刊:
影响因子:
8
通讯作者:
Gera J
Gera J
中科院分区:
医学1区
文献类型:
--
作者:
Holmes B;Benavides-Serrato A;Freeman RS;Landon KA;Bashir T;Nishimura RN;Gera J

文献摘要

参考文献

被引文献

相似文献

Overexpression of Rictor has been demonstrated to result in increased mTORC2 nucleation and activity leading to tumor growth and increased invasive characteristics in glioblastoma multiforme (GBM). However the mechanisms regulating Rictor expression in these tumors is not clearly understood. In this report, we demonstrate that Rictor is regulated at the level of mRNA translation via HSF1-induced HuR activity. HuR is shown to directly bind the 3′ UTR of the Rictor transcript and enhance translational efficiency. Moreover, we demonstrate that mTORC2/AKT signaling activates HSF1 resulting in a feed-forward cascade in which continued mTORC2 activity is able to drive Rictor expression. RNAi-mediated blockade of AKT, HSF1 or HuR is sufficient to downregulate Rictor and inhibit GBM growth and invasive characteristics in vitro and suppresses xenograft growth in mice. Modulation of AKT or HSF1 activity via the ectopic expression of mutant alleles support the ability of AKT to activate HSF1 and demonstrate continued HSF1/HuR/Rictor signaling in the context of AKT knockdown. We further show that constitutive overexpression of HuR is able to maintain Rictor expression under conditions of AKT or HSF1 loss. The expression of these components is also examined in patient GBM samples and correlative associations between the relative expression of these factors support the presence of these signaling relationships in GBM. These data support a role for a feed-forward loop mechanism by which mTORC2 activity stimulates Rictor translational efficiency via an AKT/HSF1/HuR signaling cascade resulting in enhanced mTORC2 activity in these tumors.
DOI: 10.1038/emboj.2010.271
发表时间: 2010-12-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Oh, Won Jun;Wu, Chang-chih;Jacinto, Estela
通讯作者: Jacinto, Estela
DOI: 10.1158/2159-8290.cd-14-0971
发表时间: 2015-12
期刊: Cancer discovery
影响因子: 28.2
作者:
Cheng H;Zou Y;Ross JS;Wang K;Liu X;Halmos B;Ali SM;Liu H;Verma A;Montagna C;Chachoua A;Goel S;Schwartz EL;Zhu C;Shan J;Yu Y;Gritsman K;Yelensky R;Lipson D;Otto G;Hawryluk M;Stephens PJ;Miller VA;Piperdi B;Perez-Soler R
通讯作者: Perez-Soler R
DOI: 10.1038/oncsis.2016.34
发表时间: 2016-05-30
期刊: Oncogenesis
影响因子: 6.2
作者:
Bhattacharya K;Maiti S;Mandal C
通讯作者: Mandal C
DOI: 10.1074/jbc.m116.726927
发表时间: 2016-07-01
影响因子: 4.8
作者:
Holmes, Brent;Lee, Jihye;Gera, Joseph
通讯作者: Gera, Joseph
DOI: 10.1158/1535-7163.mct-11-0478
发表时间: 2011-12-01
影响因子: 5.7
作者:
Cloninger, Cheri;Bernath, Andrew;Gera, Joseph
通讯作者: Gera, Joseph